The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGILE THERAPEUTICS INC | COM | 00847L100 | 12,028 | 1,580,491 | SH | SOLE | 1,580,491 | 0 | 0 | ||
| AMERICAN CAP SR FLOATING LTD | COM | 02504D108 | 157 | 15,255 | SH | SOLE | 15,255 | 0 | 0 | ||
| BERKSHIRE HATHAWAY INC DEL | CL B NEW | 084670702 | 1,295 | 8,945 | SH | SOLE | 8,945 | 0 | 0 | ||
| CELATOR PHARMACEUTICALS INC | COM | 15089R102 | 67,370 | 2,232,272 | SH | SOLE | 2,232,272 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 194 | 18,807 | SH | SOLE | 18,807 | 0 | 0 | ||
| CM FIN INC | COM | 12574Q103 | 295 | 33,247 | SH | SOLE | 33,247 | 0 | 0 | ||
| CSW INDUSTRIALS INC | COM | 126402106 | 367 | 11,253 | SH | SOLE | 11,253 | 0 | 0 | ||
| DOVER CORP | COM | 260003108 | 223 | 3,224 | SH | SOLE | 3,224 | 0 | 0 | ||
| GARRISON CAP INC | COM | 366554103 | 152 | 15,104 | SH | SOLE | 15,104 | 0 | 0 | ||
| MEDLEY CAP CORP | COM | 58503F106 | 167 | 24,913 | SH | SOLE | 24,913 | 0 | 0 | ||
| PARATEK PHARMACEUTICALS INC | COM | 699374302 | 263 | 18,909 | SH | SOLE | 18,909 | 0 | 0 | ||
| STELLUS CAP INVT CORP | COM | 858568108 | 304 | 29,728 | SH | SOLE | 29,728 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 143 | 35,977 | SH | SOLE | 35,977 | 0 | 0 | ||
| SYNTA PHARMACEUTICALS CORP | COM | 87162T206 | 5,665 | 21,770,662 | SH | SOLE | 21,770,662 | 0 | 0 | ||
| SYNTA PHARMACEUTICALS CORP | COM | 87162T206 | 19 | 72,000 | SH | Call | SOLE | 72,000 | 0 | 0 | |